The aims of treatment One of the aims of treatment of urinary tract infection is to relieve distressing symptoms as quickly as possible. Another is to prevent recurrent infections in those children who experience frequently recurring symptomatic urinary tract infection. A third objective is to prevent infections in children who are deemed to be at greatest risk of developing reflux nephropathy or other forms of renal damage-that is, the very young child with vesicoureteric reflux. The management of urinary tract infection in childhood has been reviewed extensively by Jodal and Winberg,' McCracken,2 and White.3 Before the start of treatment it is essential that the urine is examined microscopically and sent to the laboratory for culture, sensitivity, and colony counting. In infants suprapubic aspiration of urine under ultrasound control is the method of choice and where bag collection is used there will inevitably be a significant contamination rate with an appreciable number of false negative and false positive results leading in some cases to a delay in the onset of treatment and in others to unnecessary investigation. The risk of diagnostic error can be reduced by collecting two bag or clean catch samples and by the use of microscopy at the bedside. It is unacceptable to wait 48 hours for the results of culture and sensitivity before starting treatment in an infant or acutely symptomatic child. Paediatricians should become accustomed to making the diagnosis on the presence of white cells and organisms on direct microscopy of the unspun urine. As urinary tract infection in infancy rarely presents with symptoms localised to the urinary tract,4 and delay in treatment may result in permanent renal damage5 6 especially in the youngest children,7 every sick infant needs urgent urine examination.
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While management of the acute or presenting urinary tract infection is relatively straightforward, the long term management of recurrent urinary tract infections, mainly in girls, and the use of prophylactic antibiotics for the prevention of reflux nephropathy is both complex and controversial. It is intimately connected with other aspects of long term management and investigation, and by the natural history and epidemiology of urinary tract infection.
Swedish data suggest that the commonest age for the first urinary tract infection is the first year of life8 and that the risk in childhood decreases thereafter. Although the incidence is higher in boys in the first month, by six months urinary tract infections are more prominent in girls. Recurrent urinary tract infections occur in more than half the girls affected, but are uncommon in boys. short courses of treatment when their symptoms flare up. The drugs that have been shown to be effective in preventing reinfection are nitrofurantoin'7 and trimethoprim.'8 They are both used in doses of 1-2 mg/kg/day given usually as a nightly bolus; this is well below the normal therapeutic dose. Side effects have been relatively uncommon with both these drugs, but recently there has been some anxiety about the small risk of pulmonary and hepatic fibrosis in children taking nitrofurantoin for prolonged periods.'9 Amoxycillin, cephalosporins, and nalidixic acid are relatively ineffective as prophylactic agents probably because the bowel soon becomes colonised with E coli resistant to the drug taken.20 Reinfection of the urinary tract, when it occurs, is likely to be with a resistant organism. Co-trimoxazole is also effective as a prophylactic agent but the greater risk of side effects and complications from the sulphamethoxasole component of this trimethoprim combination have lead to a reduction in the use of this drug in the long term management of urinary tract infection in childhood.2' Single dose and short course treatment Single dose treatment and very short course treatment is attractive because it is associated with improved compliance and reduced side effects and cost, and it was used successfully in adolescent girls by Fine and Jacobson.22 There is evidence to suggest that those who have an early recurrence of infection may have upper tract infection or underlying abnormality. It has been suggested in adults that single dose treatment could be used as a method of screening for those who need further investigation.
In a randomised controlled study in children and adults Bailey and Abbott showed that the cure rate after a single dose of amoxycillin was as effective as a one week course.23 Others, however, have found that early recurrence after 10 days was more likely to occur after single dose treatment than a one week course, although most recurrences were asymptomatic. It would be prudent therefore to use single dose treatment in girls over 5 years of age with grossly normal urinary tracts in whom the risk of progressive damage is minimal, but to treat younger children and those with abnormal urinary tracts, systemic, or upper tract symptoms with longer courses.
When not to treat There are now a number of long term follow up studies in schoolgirls with asymptomatic bacteriuria that show that this is a benign condition in girls with radiologically normal kidneys over 4 years of age even if vesicoureteric reflux is present.'5 16 Reflux nephropathy once established progresses very slowly in a small proportion of cases and usually when vesicoureteric reflux is present and reinfection occurs. There is no clear evidence that long term low dose prophylaxis is superior to no treatment in asymptomatic children, however, as reinfection with new organisms may be more damaging to the kidney than continuous infection with an organism of low pathogenicity.25 In girls the natural history is for reinfection to occur in a high proportion after treatment has been discontinued. Conventional courses of treatment are doomed to failure in a large proportion of girls, therefore, and long term low dose prophylaxis is less successful in asymptomatic infection because of poor compliance and lack of motivation. In boys conventional courses may be used effectively as reinfection is rarely a problem except in the grossly abnormal urinary tract.
The grossly abnormal urinary tract Recurrent asymptomatic infection is relatively common in children with neurogenic bladders or where there is gross dilatation or stasis of the urinary tract, a ureterostomy, after bladder reconstruction, or renal calculi, and in those children using self intermittent catheterisation. It is usual to treat the infection when it first comes to medical attention, particularly in children under 2 years, but infections that recur after three or four courses of appropriate antibiotic treatment in the absence of appreciable symptoms are likely to continue to recur after further courses. The organisms may become increasingly difficult to treat, however, because of acquired antibiotic resistance. It is important to ensure that proper surgical management has been carried out-for example, removal of all urinary calculi, relief of obstruction, and proper management of the neurogenic bladder. Although prophylaxis is helpful in some cases, repeated breakthrough infections often become a problem in these children. In this situation it is best to leave the infection untreated unless symptoms become troublesome or surgery is planned. The child can then be given a five to 10 day course of appropriate treatment, until there is clinical improvement, or surgery has been completed. The choice of antibiotic may be difficult and these children with multiply resistant organisms such as proteus, pseudomonas, and E coli usually require treatment with expensive newer intravenous antibiotics rather than first line drugs. 
